0:15 New blood test can detect 50 kinds of cancer – Experts say it could revolutionize cancer care. It’s called the Galleri test and it can identify cancers before symptoms appear. The UK National Health Service is testing it on 142,000 people. If successful, this trial will be extended to 1 million people next year. Doctors hope 5,000 cases could be detected early as a result. The Galleri test works by identifying changes in bits of free-floating DNA that leak from tumours into the bloodstream. #cancer #bloodtest #nhs #dna
1:36 5 exciting emerging technologies – The World Economic Forum has published its Top 10 Emerging Technologies of 2023 Report. It draws on the expertise of more than 90 academics, industry leaders and futurists to discover the technologies most likely to impact people and the planet in the next 3-5 years. Which emerging technology are you most excited about?
3:17 This tablet is an innovation for the visually impaired – The Dot Pad lets visually impaired users play games and browse the web on the world’s first smart tactile graphics display. It uses AI to analyse images and split them into segments. Reproducing them on a tactile screen so blind people can read and interact with them.
4:58 Feminist economist dissects gender-neutral policies – Economic policies can either reinforce gender inequality, says Valeria Esquivel or help end it.
_____________________________________________
The World Economic Forum is the International Organization for Public-Private Cooperation. The Forum engages the foremost political, business, cultural and other leaders of society to shape global, regional and industry agendas. We believe that progress happens by bringing together people from all walks of life who have the drive and the influence to make positive change.
Staff Writer Jocelyn Kaiser joins Sarah to talk about a recent Science paper describing the results of a large study on a blood test for multiple types of cancer. The trial’s results suggest such a blood test combined with follow-up scans may help detect cancers early, but there is a danger of too many false positives. 
“This proof of concept study demonstrates a new paradigm that measurement of blood proteins can accurately deliver health information that spans across numerous medical specialties and that should be actionable for patients and their healthcare providers,” said Peter Ganz, MD, co-leader of this study and the Maurice Eliaser distinguished professor of medicine at UCSF and director of the Center of Excellence in Vascular Research at Zuckerberg San Francisco General Hospital and Trauma Center. 
Boomers Daily 